Prostate cancer generally has a good prognosis. In developed countries, five-year net survival exceeds 93% thanks to better diagnostics and targeted treatments. 

Care is risk-adapted: active surveillance for low-risk disease, surgery or radiotherapy for significant localized tumors.

Today’s news: Björn Borg says he is in remission after a 2024 operation for an “extremely aggressive” prostate cancer, with checkups every six months.

His case underlines strong cure rates when detected and treated early.